Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Erica Chilson, Daniel A. Scott, Beate Schmoele-Thoma, Wendy Watson, Mary M. Moran & Raul Isturiz. (2020) Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in patients with immunocompromising conditions: a review of available evidence. Human Vaccines & Immunotherapeutics 16:11, pages 2758-2772.
Read now
Read now
Susanna Esposito & Nicola Principi$suffix/text()$suffix/text(). (2017) Strategies to develop vaccines of pediatric interest. Expert Review of Vaccines 16:2, pages 175-186.
Read now
Read now
Karen Ciprero, Kirill A. Zykov, Nikolay I. Briko, Tulin Shekar, Tina M. Sterling, Elizaveta Bitieva, Jon E. Stek & Luwy Musey. (2016) Safety and immunogenicity of a single dose 23-valent pneumococcal polysaccharide vaccine in Russian subjects. Human Vaccines & Immunotherapeutics 12:8, pages 2142-2147.
Read now
Read now
Susanna Esposito, Paolo Bonanni, Stefania Maggi, Litjan Tan, Filippo Ansaldi, Pier Luigi Lopalco, Ron Dagan, Jean-Pierre Michel, Pierre van Damme, Jacques Gaillat, Roman Prymula, Timo Vesikari, Cristina Mussini, Uwe Frank, Albert Osterhaus, Lucia Pastore Celentano, Marta Rossi, Valentina Guercio & Gaetan Gavazzi. (2016) Recommended immunization schedules for adults: Clinical practice guidelines by the Escmid Vaccine Study Group (EVASG), European Geriatric Medicine Society (EUGMS) and the World Association for Infectious Diseases and Immunological Disorders (WAidid). Human Vaccines & Immunotherapeutics 12:7, pages 1777-1794.
Read now
Read now
Articles from other publishers (8)
Ravinder Kaur, Eduardo Gonzalez, Minh Pham & Michael Pichichero. (2023) Naturally-induced serum antibody levels in children to pneumococcal polysaccharide 15B that correlate with protection from nasopharyngeal colonization but anti-serotype 15B antibody has low functional cross-reactivity with serotype 15C. Vaccine 41:48, pages 7265-7273.
Crossref
Crossref
Brandon Essink, Charu Sabharwal, Kevin Cannon, Robert Frenck, Himal Lal, Xia Xu, Vani Sundaraiyer, Yahong Peng, Lisa Moyer, Michael W Pride, Ingrid L Scully, Kathrin U Jansen, William C Gruber, Daniel A Scott & Wendy Watson. (2022) Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 Years. Clinical Infectious Diseases 75:3, pages 390-398.
Crossref
Crossref
Theano Lagousi, Ioanna Papadatou, Petros Strempas, Elena Chatzikalil & Vana Spoulou. (2021) Pneumococcal Immunization Strategies for High-Risk Pediatric Populations Worldwide: One Size Does Not Fit All. Vaccines 9:12, pages 1390.
Crossref
Crossref
Ravinder Kaur & Michael Pichichero. (2020) Comparison of anti-capsular antibody quantity and functionality in children after different primary dose and booster schedules of 13 valent-pneumococcal conjugate vaccine. Vaccine 38:28, pages 4423-4431.
Crossref
Crossref
Antonia C. Perez, Antoinette Johnson, Ziqiang Chen, Gregory E. Wilding, Michael G. Malkowski & Timothy F. Murphy. (2018) Mapping Protective Regions on a Three-Dimensional Model of the Moraxella catarrhalis Vaccine Antigen Oligopeptide Permease A. Infection and Immunity 86:3.
Crossref
Crossref
Mathilde Bahuaud, Hélène Bodilis, Marion Malphettes, Anaïs Maugard Landre, Caroline Matondo, Didier Bouscary, Frédéric Batteux, Odile Launay & Jean-Paul Fermand. (2017) Immunogenicity and persistence of the 13-valent Pneumococcal Conjugate Vaccine (PCV13) in patients with untreated Smoldering Multiple Myeloma (SMM): A pilot study. Heliyon 3:11, pages e00441.
Crossref
Crossref
Fiona McGill, Robert S Heyderman, Stavros Panagiotou, Allan R Tunkel & Tom Solomon. (2016) Acute bacterial meningitis in adults. The Lancet 388:10063, pages 3036-3047.
Crossref
Crossref
Marta Valente Pinto, Smiti Bihari & Matthew D. Snape. (2016) Immunisation of the immunocompromised child. Journal of Infection 72, pages S13-S22.
Crossref
Crossref